Feola S

Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.

Manfredi F, Stasi L, Buonanno S, ..., Bonini C, Ruggiero E

Sci Adv 9 (48) eadg8014 [2023-12-00; online 2023-12-01]

Development of mesothelioma-specific oncolytic vaccine exploiting immunopeptidomic analysis of murine and human tumors

Chiaro J, Antignani G, Feola S, ..., Lehtiö J, Cerullo V

- - (-) - [2022-11-08; online 2022-11-08]

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines.

Feola S, Chiaro J, Martins B, ..., Lehtiö J, Cerullo V

Elife 11 (-) - [2022-03-22; online 2022-03-22]

Author response: A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

Feola S, Chiaro J, Martins B, ..., Lehtiö J, Cerullo V

- - (-) - [2022-02-22; online 2022-02-22]

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

Feola S, Chiaro J, Martins B, ..., Lehtiö J, Cerullo V

- - (-) - [2021-06-09; online 2021-06-09]